Post-transplant cyclophosphamide, abatacept, and short course of tacrolimus combination (CAST) is safe and seems highly effective in preventing graft-versus-host disease following haploidentical peripheral blood stem cell transplantation

Category Primary study
JournalBlood
Year 2021
This article has no abstract
Epistemonikos ID: 4f86da36a267502341e276a2e6931637aaf8466d
First added on: Feb 13, 2025